Health Technology Assessment - Do Evidence-based Data for Prevention and Control of MRSA Exist?;Ein Health Technology Assessment - Was ist Wissenschaftlich Gesichert zur Prävention, und Kontrolle von MRSA?

Klinikarzt

Volumn 33, Issue 1-2, 2004, Pages 15-20

  Dettenkofer, Markus ^a   Merkel, H ^a   Mutter, J ^a   Daschner, F ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Health technology assessment; Infection; MRSA; Prevention; Restistance

Indexed keywords

ARTICLE; BACTERIAL COLONIZATION; CLINICAL RESEARCH; GERMANY; HAND WASHING; HOSPITAL HYGIENE; HOSPITAL INFECTION; HOSPITAL PERSONNEL; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

EID: 1142286773     PISSN: 03412350     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-819023     Document Type: Article

References (24)

1. Arbeitskreis für Krankenhaushygiene. Magnahmen beim Auftreten multiresistenter Erreger (MRE). http://www.uni-duesseldorf.dorf.de/WWW/AWMF/II/kh_d-018.htm (Stand: Nov. 2000)
2. Bijl D, Voss A. Infection control in the Netherlands. J Hosp Infect 2001; 47: 169-172
3. Boyce JM. MRSA patients: proven methods to treat colonization and infection. J Hosp Infect 2001; 48: 9-14
4. Cosgrove SE, Sakoulas G, Perencevich EN et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 36: 53-59
5. Dettenkofer M, Merkel H, Mutter J. Kurz-HTA: Bewertung unterschledlicher Hygienekonzepte zur Kontrolle von MRSA (Methicillin-resistente Staphylococcus aureus). Deutsches Institut für Medizinische Dokumentation und Information (DIMDI), HTA26, 2002; http://www.dimdi.de/de/hta/hta_berichte/hta26_text.pdf
6. Dettenkofer M, Forster DH, Ebner W et al. The practice of perioperative antibiotic prophylaxis in eight German hospitals. Infection 2002; 30: 164-167
7. Dziekan G, Hahn A, Thune K et al. Methicillin-resistant Staphylococcus aureus in a teaching hospital: investigation of nosocomial transmission using a matched case-control study. J Hosp Infect 2000; 46: 263-270
8. EARSS, European Antimicrobial Resistance Surveillance System. Annual Report 2001. http://www.earss.rivm.nl (Internet-seite, Stand 18.10.2002)
9. Enright MC, Robinson DA, Randle G et al. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). PNAS 2002; 99: 7687-7692
10. Fitzner J, Kappstein I, Dietzkan G et al. Hygienemagnahmen bei Patienten mit Methicillin-resistenten Staphylococcus aureus (MRSA). Deutsche Med Wochenschrift 2000; 125: 368-371
11. Garner JS, the Hospital Infection Control Practices Advisory Committee. Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996; 17: 54-80
12. Gastmeier P, Schwab F, Geffers C, Rüden H. Is the strict isolation of MRSA patients really necessary? Analysis of data from the German nosocomial infection surveillance system KISS. Posterbeitrag 5th International Conference of the Hospital Infection Society, Edinburgh 2002, P5.03.
13. Harbarth S, Albrich W, Goldmann DA, Huebner J. Control of multiply resistant cocci: do international comparisons help? Lancet Infectious Diseases 2001; 1: 251-261
14. Jernigan JA, Titus MG, Groschel DH et al. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am J Epidemiol 1996; 143: 496-504
15. Karchmer TB, Durbin LJ, Simonton BM, Farr BM. Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2002; 51: 126-132
16. Mindorff CM, Cook DJ. Critical review of the hospital epidemiology and infection control literature. In: Mayhall CG (ed). Hospital epidemiology and infection control (2. Auflage). Philadelphia: Lippincott Williams & Wilkins, 1999, 1273-1281
17. Robert Koch-Institut, Kommission für Krankenhaushygiene und Infektionsprävention. Empfehlung zur Prävention und Kontrolle von Methicillin-resistenten Staphylococcus aureus-Stämmen (MRSA) in Krankenhäusern und anderen medizinischen Einrichtungen. Bundesgesundheitsbl 1999; 42: 954-958
18. Rubin MA, Samore MH. Antimicrobial use and resistance. Curr Infect Dis Rep 2002; 4: 491-497
19. Rubinovitch B, Pittet D. Screening for methicillin-resistant Staphylococcus aureus in the endemic hospital: what have we learned? J Hosp Infect 2001; 47: 9-18
20. Rüden H, Daschner F, Gastmeier R Krankenhausinfektionen - Empfehlungen für das Hygienemanagement. Berlin, Heidelberg, New York, Tokio: Springer, 2000
21. Tenover FC. Development and spread of bacterial resistance to antimicrobial agents: an overview. Clin Infect Dis 2001; 33: 108-115
22. Vriens M, Blok H, Flult A et al. Costs associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch university medical center: A 10-Year Survey. Eur J Clin Microbiol Infect Dis 2002; 21: 782-786
23. Weist K, Rüden H. Sind die Präventionsmaßnahmen in deutschen Kliniken zu aufwändig? klinikarzt 2001; 30: 205-210
24. Widmer A. Welche Präventionsmaßnahmen müssen sein? (Leserbrief). klinikarzt 2001; 30: XXIV